[1]
Heesakkers, J., te Dorsthorst, M. and Wagg, A. 2022. Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder. Canadian Geriatrics Journal. 25, 1 (Mar. 2022), 72–78. DOI:https://doi.org/10.5770/cgj.25.530.